AXIN1
関連文献

“Colorectal cancer and genetic alterations in the Wnt pathway.”. Oncogene 25 (57):  7531–7. (2007). doi:10.1038/sj.onc.1210059. PMID 17143297.
“The relationship between chromosome structure and function at a human telomeric region”. Nat. Genet. 15 (3):  252–7. (1997). doi:10.1038/ng0397-252. PMID 9054936.
“Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin”. EMBO J. 17 (5):  1371–84. (1998). doi:10.1093/emboj/17.5.1371. PMC 1170485. PMID 9482734. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1170485/.
“Downregulation of beta-catenin by human Axin and its association with the APC tumor suppressor, beta-catenin and GSK3 beta”. Curr. Biol. 8 (10):  573–81. (1998). doi:10.1016/S0960-9822(98)70226-X. PMID 9601641.
“Axin, an inhibitor of the Wnt signalling pathway, interacts with beta-catenin, GSK-3beta and APC and reduces the beta-catenin level”. Genes Cells 3 (6):  395–403. (1998). doi:10.1046/j.1365-2443.1998.00198.x. PMID 9734785.
“Identification of a domain of Axin that binds to the serine/threonine protein phosphatase 2A and a self-binding domain”. J. Biol. Chem. 274 (6):  3439–45. (1999). doi:10.1074/jbc.274.6.3439. PMID 9920888.
“An F-box protein, FWD1, mediates ubiquitin-dependent proteolysis of beta-catenin”. EMBO J. 18 (9):  2401–10. (1999). doi:10.1093/emboj/18.9.2401. PMC 1171323. PMID 10228155. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1171323/.
“Domains of axin involved in protein-protein interactions, Wnt pathway inhibition, and intracellular localization”. J. Cell Biol. 145 (4):  741–56. (1999). doi:10.1083/jcb.145.4.741. PMC 2133179. PMID 10330403. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2133179/.
“Axin directly interacts with plakoglobin and regulates its stability”. J. Biol. Chem. 274 (39):  27682–8. (1999). doi:10.1074/jbc.274.39.27682. PMID 10488109.
“A GSK3beta phosphorylation site in axin modulates interaction with beta-catenin and Tcf-mediated gene expression”. Biochem. Biophys. Res. Commun. 266 (1):  28–35. (2000). doi:10.1006/bbrc.1999.1760. PMID 10581160.
“GSK-3beta-dependent phosphorylation of adenomatous polyposis coli gene product can be modulated by beta-catenin and protein phosphatase 2A complexed with Axin”. Oncogene 19 (4):  537–45. (2000). doi:10.1038/sj.onc.1203359. PMID 10698523.
“AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1”. Nat. Genet. 24 (3):  245–50. (2000). doi:10.1038/73448. PMID 10700176.
“Structural basis of the Axin-adenomatous polyposis coli interaction”. EMBO J. 19 (10):  2270–9. (2000). doi:10.1093/emboj/19.10.2270. PMC 384355. PMID 10811618. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC384355/.
“Dimerization choices control the ability of axin and dishevelled to activate c-Jun N-terminal kinase/stress-activated protein kinase”. J. Biol. Chem. 275 (32):  25008–14. (2000). doi:10.1074/jbc.M002491200. PMID 10829020.
“Sequence, structure and pathology of the fully annotated terminal 2 Mb of the short arm of human chromosome 16”. Hum. Mol. Genet. 10 (4):  339–52. (2001). doi:10.1093/hmg/10.4.339. PMID 11157797.
“Inhibition of the Wnt signaling pathway by the PR61 subunit of protein phosphatase 2A”. J. Biol. Chem. 276 (29):  26875–82. (2001). doi:10.1074/jbc.M100443200. PMID 11297546.
“Low-density lipoprotein receptor-related protein-5 binds to Axin and regulates the canonical Wnt signaling pathway”. Mol. Cell 7 (4):  801–9. (2001). doi:10.1016/S1097-2765(01)00224-6. PMID 11336703.
“Axin facilitates Smad3 activation in the transforming growth factor beta signaling pathway”. Mol. Cell. Biol. 21 (15):  5132–41. (2001). doi:10.1128/MCB.21.15.5132-5141.2001. PMC 87238. PMID 11438668. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC87238/.
“Axin-dependent phosphorylation of the adenomatous polyposis coli protein mediated by casein kinase 1epsilon”. J. Biol. Chem. 276 (42):  39037–45. (2001). doi:10.1074/jbc.M105148200. PMID 11487578.